Compare DraftKings Inc (DKNG) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DraftKings Inc vs Edwards Lifesciences Corporation Common Stock — how do they compare? DraftKings Inc trades at $19.58 (market cap $9.86B), while Edwards Lifesciences Corporation Common Stock trades at $85.19 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 4.9× DraftKings Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.
| DKNG | EW | |
|---|---|---|
Market Cap | $9.86B | $48.56B |
Volume | 16,584,596 | 6,520,488 |
Sector | Consumer Cyclical | Health |
52-Week High | $36.24 | $95.18 |
52-Week Low | $18.59 | $72.65 |
Typical Hold Time | 55 Days | — |
Enterprise Value | $10.80B | $45.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DraftKings (DKNG) trades at $19.58, down 7.4% recently and near a 52-week low of $18.95, reflecting bearish technical signals. The company achieved profitability in 2025 with $6.05B revenue and $3.71M net income, but Q2 2026 EPS missed estimates. Analyst consensus remains strongly bullish with a $33.13 price target, though high valuation multiples and recent earnings volatility pose concerns.
Long-term prospects are supported by revenue growth and strategic initiatives like the DKeX rollout and NHL sponsorship, targeting $1B EBITDA in 2026. However, risks include competitive pressures, regulatory uncertainty in markets like Brazil, and the stock's sensitivity to growth deceleration. Investors should weigh strong analyst optimism against fundamental execution risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DraftKings Inc
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
